Magnetic resonance imaging (MRI) can track progenitor cells following direct intramyocardial injection. However, in the vast majority of post-myocardial infarction (MI) clinical trials, cells are delivered by the intracoronary (IC) route, which results in far greater dispersion within the myocardium. Therefore, we assessed whether the more diffuse distribution of cells following IC delivery could be imaged longitudinally with MRI. In 11 pigs (7 active, 4 controls), MI was induced by 90-min balloon occlusion of the left anterior descending coronary artery. Seven (0) days [median (interquartile range)] following MI, bone marrow progenitor cells (BMCs) were colabeled with an iron-fluorophore and a cell viability marker and delivered to the left anterior descending coronary artery distal to an inflated over-the-wire percutaneous transluminal coronary angioplasty balloon. T2*-weighted images were used to assess the location of the magnetically labeled cells over a 6-wk period post-MI. Immediately following cell delivery, hypointensity characteristic of the magnetic label was observed in the infarct border rather than within the infarct itself. At 6 wk, the cell signal hypointensity persisted, albeit with significantly decreased intensity. BMC delivery resulted in significant improvement in infarct volume and ejection fraction (EF): infarct volume in cell-treated animals decreased from 7.1 Ϯ 1.5 to 4.9 Ϯ 1.0 ml (P Ͻ 0.01); infarct volume in controls was virtually unchanged at 4.64 Ϯ 2.1 to 4.39 Ϯ 2.1 ml (P ϭ 0.7). EF in cell-treated animals went from 30.4 Ϯ 5.2% preinjection to 34.5 Ϯ 2.5% 6 wk postinjection (P ϭ 0.013); EF in control animals went from 34.3 Ϯ 4.7 to 31.9 Ϯ 6.8% (P ϭ 0.5). Immunohistochemical analysis revealed intracellular colocalization of the iron fluorophore and cell viability dye with the labeled cells continuing to express the same surface markers as at baseline. MRI can track the persistence and distribution of magnetically labeled BMCs over a 6-wk period following IC delivery. Signal hypointensity declines with time, particularly in the first week following delivery. These cells maintain their original phenotype during this time course. Delivery of these cells appears safe and results in improvement in infarct size and left ventricular ejection fraction. magnetic resonance imaging; myocardial infarction ATHEROSCLEROTIC CORONARY ARTERY disease is widely prevalent and is the commonest cause of premature death in the developed world (21). In patients surviving myocardial infarction (MI), progressive left ventricular (LV) dilation and reduced ejection fraction are major determinants of the development of heart failure and poor long-term survival. Recent studies have assessed the administration of bone marrow progenitor cells (BMCs) as a means of improving cardiac function post-MI and preventing deleterious negative LV remodeling (3, 22, 24, 25, 29) . Clinical studies have shown that administration of these cells is safe, but their efficacy varies widely, a finding that may largely be explained by differences in trial design, including method of administration, timing of administration following MI, cell type utilized, and mode of assessing efficacy (1, 12, 18, 28) .
(MI), progressive left ventricular (LV) dilation and reduced ejection fraction are major determinants of the development of heart failure and poor long-term survival. Recent studies have assessed the administration of bone marrow progenitor cells (BMCs) as a means of improving cardiac function post-MI and preventing deleterious negative LV remodeling (3, 22, 24, 25, 29) . Clinical studies have shown that administration of these cells is safe, but their efficacy varies widely, a finding that may largely be explained by differences in trial design, including method of administration, timing of administration following MI, cell type utilized, and mode of assessing efficacy (1, 12, 18, 28) .
Long-term cell retention is highest following direct intramyocardial injection (7) . However, due to ease of delivery, the majority of clinical studies have utilized intracoronary infusion via the infarct related artery. Using radionuclide labeling and positron emission tomography, it has been shown that cellular retention following intracoronary delivery is only 1.3-2.6% for unselected bone marrow cells, although this may rise to 39% with CD34-enriched cells (11) . Positron emission tomography is a highly sensitive method to follow cell fate in the short term, but is limited by poor spatial resolution, cellular toxicity of the radiotracer, and relatively short half-life of the radiotracer, which precludes long-term tracking (13) .
Magnetic resonance imaging (MRI) has been used to track cells longitudinally following direct intramyocardial injection (9, 16) and acutely following intracoronary infusion (4) . However, the intracoronary route, by its very nature, results in a more diffuse and less dense distribution of cells, which will be more difficult to visualize. Thus, in this present study, we tested whether MRI could be used for long-term tracking of iron-fluorophore labeled autologous BMCs after intracoronary infusion in a porcine model of MI.
METHODS
Studies were conducted in 11 Yorkshire swine (22-28 kg) . All studies were approved by the Sunnybrook Health Sciences Animal Ethics Committee, in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication no. 85-23, revised 1996) .
Animal Premedication
Premedication consisted of a ketamine/atropine cocktail (35 mg/kg ketamine hydrochloride and 0.05 mg/kg atropine) and masking at 5% halothane in oxygen. Anesthesia was maintained using 2% isofluorane. To minimize arrhythmias, animals received a preoperative intravenous bolus, followed by constant infusion of both amiodarone (75 mg bolus, 1.5 mg·kg Ϫ1 ·h Ϫ1 infusion) and lidocaine (20 mg bolus, 3 mg·kg Ϫ1 ·h Ϫ1 infusion). Animals also received metoprolol during the 5-day interval before experimentation (50 mg/day, in feed). Periprocedural anticoagulation was given in the form of intravenous unfractionated heparin (70 -90 U/kg).
Cellular Preparation
Immediately before infarct creation, bone marrow (40 -50 ml) was aspirated from both iliac crests. The mononuclear fraction was obtained using Ficoll gradient centrifugation (Cell Preparation Tube, Becton Dickinson, Franklin Lakes, NJ). This mononuclear fraction was aspirated, washed twice, and plated on human fibronectin-coated flasks in endothelial basal medium (EBM-2, Cambrex BioScience, East Rutherford, NJ), supplemented with endothelial growth medium SingleQuots (EGM-2MV) and 20% fetal bovine serum (26) and cultured for 7 days with media changes every 48 -72 h.
Before cell injection, the cells were incubated for 12-18 h with super-paramagnetic iron oxide particles conjugated with a fluorescent dye. These iron fluorophores (Bangs Laboratories, Fisher, IN) have an average size of 0.9 m, contain both magnetite iron oxide, as well as a fluorescein-5-isocyothianate analog (Dragon Green), and are readily taken up by dividing cells. Incubation was at a concentration of 10 l/ml, which has previously been shown to have no effect on cellular differentiation, migration, and proliferation in several cell lineages (10) . To assess both labeling efficacy (using Dragon Green fluorescence) and viability postlabeling using propidium iodide staining, flow cytometric analysis was performed 1 day after the cells had undergone a 16-h period of incubation with Bangs particles. After this incubation period, the cells were washed twice in phosphate-buffered saline (PBS) and incubated for 30 min with a fluorescent cell viability marker, Cell Tracker Orange [orange-fluorescent tetramethylrhodamine: 5-(and-6)-{[(4-chloromethyl)benzoyl]amino} tetramethylrhodamine (CMTMR); Invitrogen, Burlington, ON]. Following this second incubation, they were again washed twice in PBS, trypsinized, washed twice in PBS, and made up to a final volume of 2 ml in PBS. Immediately before injection, cell viability was confirmed using Trypan blue exclusion. Animals were randomly assigned to receive either active cells or an equal volume of the PBS vehicle.
Cellular Identification
BMCs were cultured on fibronectin-coated glass coverslips for 1-2 days, then fixed with 4% parafromaldehyde for 15 min. Blocking was achieved with 10% goat serum, 3% bovine serum albumin, and 0.5% Triton X-100 in 1ϫ PBS (blocking solution). Primary antibody staining was completed overnight at 4°C for the following antibodies: rabbit anti-human KDR (ab2349, Abcam, Cambridge, MA), rabbit anti-human CD133 (ab19898, Abcam), goat anti-porcine CD34 (2E9, 550427, BD Biosciences, Mississauga, ON, Canada), mouse antiporcine CD45 (clone K252-1E-4, NB100-64892, Novus Biologicals, Littleton, CO), mouse anti-human CD146 (clone P1H12, ab78451, Abcam), and mouse anti-myosin heavy chain class I (H58A, VMRD, Pullman, WA). Appropriately matched secondary antibodies were used as follows: anti-mouse IgG-FITC, anti-rabbit IgG-FITC (SigmaAldrich, St. Louis, MO), and anti-goat IgG-FITC (Jackson ImmunoResearch, West Grove, PA), for 30 min at room temperature. Samples were counterstained with 4,6-diamidino-2-phenylindole (DAPI) (Sigma) and mounted with Dako fluorescence mount (Dako Canada, Mississauga, ON, Canada).
Infarct Creation
An anterior MI was created via a percutaneous approach, as previously described (5) . Briefly, the femoral artery was cannulated, and the left anterior descending coronary artery (distal to the second diagonal branch) was occluded for 90 min using a conventional angioplasty balloon catheter. Postprocedure angiography confirmed the reperfused nature of the infarct by demonstrating left anterior descending coronary artery patency.
Cellular Delivery
Seven (0) days [median (interquartile range)] following MI, the animals were reanesthetized and instrumented, and an over-the-wire (OTW) angioplasty balloon (Guidant Opensail, Abbott Laboratories, Abbott Park, IL) was advanced to the previous site of infarct creation. In an attempt to minimize cellular washout, the cells were hand injected through the central lumen of the OTW balloon during two 1-min periods of low-pressure inflation. To minimize further ischemia, the balloon was deflated for 1 min between cell injections.
Imaging
All MRI studies were performed on a GE 1.5-T Signa Excite system (GE Healthcare, Milwaukee, WI). The animal was placed in a plexiform case to allow scanning in the supine position. A 5-in. surface or general purpose flex coil was placed on the anterior thoracic wall of the animal. Cardiac gating was achieved utilizing vector gating or, if inadequate, through a plethysmography trace using an Invivo Magnitute physiological monitor (Invivo, Orlando, FL) received from the pig's tail. Respiratory artifacts were reduced by both securing of forelimbs to the base of the plexiform case and signal averaging. Before cell injection, all pigs underwent a baseline MRI study that included a steady-state free precession (SSFP) functional study and infarct imaging with late gadolinium hyperenhancement (LGE-MRI). The location of the cells' magnetic label was assessed using a T2*-weighted sequence, which demonstrates cellular iron as signal hypointensity. Typical MRI parameters were as follows.
SSFP. A total of 10 -16 slices covering the whole LV from the mitral valve to the apex were acquired with 5-mm-slice thickness without spacing. Repetition time (TR) ϳ4.0 ms, echo time (TE) ϳ1.4 ms, flip angle 60°, field of view 23 cm, matrix 256 ϫ 192, number of excitations (NEX) 4 -6, 20 cardiac phases per slice.
LGE T2*-weighted images. A fast GRE sequence was employed. The TE selected varied at each given time point due to the trade-off between labeled cell sensitivity and blood flow artifacts. For the data analysis and images presented in this paper, a TE of 4.7 ms was selected. TR was equal to 9.8 ms with voxels size of 0.6 ϫ 0.5 ϫ 5 mm.
-MRI (inversion recovery-prepared fast gradient echo). An LGE-MRI [inversion recovery-prepared fast gradient echo (GRE)]
Animals were imaged immediately following cell delivery and at 1 and 6 wk following cell delivery.
Tissue Analysis
Following death, the heart was explanted. The ventricular chambers were filled with an inert quick-setting polymer (Histomer, Histotech ApS, Denmark), and manually sliced into ϳ10-mm thick sections in short-axis oblique orientation, starting from the apex.
Immunohistochemistry
Myocardium from the infarct border region was fixed overnight in acetone at 4°C, cleared in methyl butyrate and xylene, then embedded in parrafin. Sections were rehydrated through xylene, alcohol, and PSB, then blocked for 1 h at room temperature in blocking solution, followed by primary antibody staining at 4°C overnight. Antibodies employed were rabbit anti-human KDR, rabbit anti-human CD133, goat anti-porcine CD34, mouse anti-porcine CD45, mouse anti-human CD146, and mouse anti-porcine CD31 (MCA1746, Serotec). To ensure the cell label is not simply leeching out of apoptototic cells and being taken up by phagocytes, frozen cryosections of 5 m were stained with an anti-human monocyte/macrophage antibody (MAC387, Chemicon, Temecula, CA) at a concentration of 1:100 overnight at 4°C. Secondary antibody staining was done at room temperature for 30 min with Cy5-conjugated anti-mouse IgG, anti-rabbit IgG, and anti-goat IgG (Jackson ImmunoResearch). Samples were counterstained with DAPI and mounted with Dako Fluorescence Mount.
Data Analysis
SSFP LV function, infarct volume, and LV mass analysis were performed on a GE Advantage workstation (version 4.2) using Mass Plus software (Medis, Leiden, the Netherlands). The operators evaluating these were blinded to which treatment group each animal had been assigned. Absolute figures for LV ejection fraction (LVEF) and infarct volume were measured, and, due to the anticipated increase in LV mass over the time period of the study, infarct volume also was expressed as a function of LV mass.
Signal Intensity Ratios
Using T2*-weighted imaging sequences, cellular iron should be visible as a hypointense (i.e., dark) signal. Comparing the signal intensity (SI) from areas of labeled cells with the SI from areas of remote (uninfarcted) myocardium will give an indirect indicator of retained cell number. The higher the number of retained labeled cells, the lower the SI ratio. For quantitative SI analysis, two regions of interest were drawn manually ( Fig. 1) : one in the area where cell signal hypointensity was deemed maximal (by visual assessment); and another in a control area unaffected by the infarct (usually the posterior-inferior segments of LV). SI values were obtained using Xcinema (Stanford University). To evaluate relative cell hypointensity (and thus an indication of cellular retention), the ratio SI(infarct)/ SI(control) was calculated at all three time points in the cell-treated animals, and at the first and last time points in the control animals.
Statistical Analysis
All data are expressed as mean value Ϯ SD or median (interquartile range), where appropriate. Differences in LVEF and infarct volume were evaluated using an unpaired Student's t-test. Statistical signifi- Fig. 4 . Sequential 5-mm slices from base of heart (left) ¡ apex (right) from one animal immediately following intracoronary injection of 1.6 ϫ 10 7 EPCs. Top: the T2*-weighted fast gradient echo (GRE) images with the hypointensity of the cells' iron label indicated by arrows. Bottom: corresponding inversion recovery-GRE images following injection of Gd-diethylenetriamine pentaacetic acid showing the transmural infarction as late gadolinium hyperenhancement. Note the hypointensity is evident around the outside of the infarct within the infarct-border region, rather than within the infarct core region.
cance was accepted when P Ͻ 0.05. The statistical analyses were performed using SPSS for Windows (SPSS, Chicago, IL).
RESULTS

Cellular Yield and Labeling Efficacy
Each animal received an average of 13 ϫ 10 6 BMCs (median 13.0 ϫ 10 6 , range 6 -22 ϫ 10 6 ). BMC viability 24 h postincubation with Bangs particles was 85%, and Ͼ99% of viable cells bore the Bangs particles label (Fig. 2) . Following the dual-labeling technique described, and before injection, viability was Ͼ99% by Trypan blue exclusion.
Cellular Identification
Following the culture techniques employed, the BMC-derived cells express typical endothelial progenitor markers, while they do not express hematopoietic or endothelial lineage markers (Fig. 3) . The cells expressed CD133, CD34, and kdr. They do not express CD45 and CD146 and are only weakly positive for major histocompatibility complex-1.
T2* CMR
Immediately following cell delivery, cardiac T2* MRI demonstrated hypointense regions within the LV, characteristic of the magnetic label, evident in all cell-treated animals (Fig. 4) . Comparison with the corresponding inversion recovery-GRE infarct images demonstrated the hypointense regions to be within the peri-infarct region.
Sequential imaging of all cell-injected animals at days 7 and 42 revealed the persistence of hypointense regions (Fig. 5) . At day 42, there was obvious myocardial thinning in the region of infarction. At 42 days, the peri-infarct location of the cellular signal could no longer be appreciated, with the signal hypointensity appearing more diffuse throughout the infarct area (Fig. 5C ).
SI
Measurement of the SI ratio [ratio SI (infarct)/SI (normal)]
revealed differences between treatment groups. Immediately following cell delivery, the value in cell-treated animals was 0.557 Ϯ 0.14 vs. 1.50 Ϯ 0.11 in controls (P ϭ 0.0093). In cell-treated animals, the SI ratio returned toward unity over the 6-wk time period, with the majority of signal hypointensity being lost in the first week following cell delivery (Table 1) . At day 7, the SI ratio was 0.864 Ϯ 0.1 (P ϭ 0.0025 vs. immediately after cell delivery), and at 6 wk 0.813 Ϯ 0.08 (P ϭ 0.0148 vs. immediate; P ϭ 0.4 vs. 1-wk value). There was no difference observed in SI ratio over the 6-wk time period in the control animals (P ϭ 0.59).
Cardiac Function
LVEF. LVEF at days 0 and 42 are presented in Table 2 . There was a 3.9% difference in EF at baseline (P ϭ 0.24). In cell-treated animals, 6 wk following intracoronary delivery of BMCs, there was a significant improvement in LVEF from 30.4 Ϯ 5.2 to 34.5 Ϯ 2.5% (P ϭ 0.013). There was no change in LVEF in PBS-infused animals over the 42-day study period, with LVEF in control animals going from 34.3 Ϯ 4.7 to 31.9 Ϯ 6.8%, P ϭ 0.5 (Table 2) .
Infarct volume. LV infarct size was larger in the cell-treated animals at baseline (7.1 Ϯ 1.5 ml) than the PBS-treated animals (4.64 Ϯ 2.1 ml), although this was not quite significant (P ϭ 0.09). When infarct volume is expressed as a function of LV mass, there was no significant difference between either group at baseline (in control animals, infarct size was 0.106 Ϯ 0.046 vs. 0.165 Ϯ 0.042 ml/g LV mass in cell-treated animals, P ϭ 0.17). LV infarct volume was unchanged in the control group over the 42-day treatment period (baseline: 4.64 Ϯ 2.1, 6 wk: 4.39 Ϯ 2.1 ml, P ϭ 0.7), while the cell-treated group demonstrated a significant decline in infarct volume (baseline: 7.1 Ϯ 1.5, 6 wk: 4.9 Ϯ 1.0 ml, 47.6 Ϯ 15.9% decline, P ϭ 0.001, Table 2 ). When expressed as a function of LV mass, the control group showed no significant difference in infarct size (P ϭ 0.13), whereas there was a significant decrease in standardized infarct volume in the cell-treated group (pretreatment: 0.165 Ϯ 0.042, posttreatment: 0.078 Ϯ 0.03 ml/g LV mass, P Ͻ 0.0001).
Immunohistochemistry
Sections from infarct regions showed cells bearing both the magnetic and fluorescent signals of Bangs particles, together with the CMTMR label. Staining with MAC387 showed sparse macrophages, which were separate from the cells containing Bangs particles/CMTMR (Fig. 6) . Analysis of cell surface markers demonstrate that, phenotypically, these labeled cells are expressing the same markers as the original transplanted cells.
DISCUSSION
This study demonstrates that cardiac magnetic resonance was able to follow the movement of magnetically labeled BMCs over a 42-day time period, following intracoronary delivery. In the early phase, magnetically labeled BMCs appeared in the peri-infarct region. These changes were associated with significant improvements in cardiac LVEF and a reduction in infarct size.
Although it has previously been reported that BMCs preferentially migrate to the infarct-border region (2, 11), we believe that the rapidity with which the BMCs appeared in this region is consistent with the direct intracoronary delivery, and the lack of labeling of the infarct core likely reflects a relative lack of perfusion of this region, or an inhospitable tissue environment for cell seeding. In contrast, Baklanov et al. (4) demonstrated feromoxide-labeled cells diffusely distributed within the infarct core itself following intracoronary infusion in a similar swine model. The longer balloon inflation used in our model (90 vs. 60 min) may explain this apparent discrepancy, since our model is associated with both microvascular obstruction and intramyocardial hemorrhage (5), both of which may limit cellular access to the infarct. Although microvascular obstruction was no longer evident on MRI at the time of cell delivery (images not shown), it is feasible that microvascular dysfunction/obstruction has persisted and has prevented penetration of the injected cells into the infarct core, initially confining them to the infarct-border region. Interestingly, 6 wk following infusion, the persisting cells appear within the infarct region itself. This may be due to active migration of the cells into the infarct, although the exact position of the cells may be affected by infarct remodeling. Active migration and homing of injected cells to regions of infarction has been shown following both intravenous and remote intramyocardial injection (17, 23) . Although this study does demonstrate persistence of injected cells, unfortunately, due to a combination of decreasing cell label signal and spatial resolution, we were unable to demonstrate potential migration over the small distance from the infarct border to the infarct core. Soto et al. (23) were able to demonstrate migration from remote, uninfarcted myocardium into infarct regions, but this followed direct intramyocardial injection over a shorter time course.
The presence of cells at the 6-wk time point is, in itself, noteworthy. In an attempt to maximize cellular retention and efficacy, we injected after a minimum of 7 days following MI, to avoid delivering cells into the acutely damaged myocardium, which may represent a poor substrate for cell engraftment (22) .
Injection of labeled cells along the central lumen of the OTW balloon catheter resulted in immediate loss of 11% of cells (data not shown). The MRI scan performed immediately following cell delivery likely visualizes iron, both within viable cells, and also extracellular iron, which has been released by the cells that sheared during catheter injection. This extracellular iron, and any other iron released by cells as they die, is presumably then cleared by macrophages and other phagocytotic cells. The rapid return of signal hypointensity toward baseline, particularly in the first week, would strengthen the argument that the majority of cells are lost acutely, either because of damage due to the injection procedures, ischemia, or apoptosis in the myocardial bed or by redistribution to other organs, such as the lung, spleen, and bone marrow. However, the observation that the signal hypointensity does not actually return to baseline suggests that labeled cells are still visible using MRI at 6 wk. It is possible that persisting iron and fluorescent signals imaged in myocardial sections could represent phagocytosis by tissue macrophages of Bang's particles released from dying cells. However, the observation that, at the 6-wk time point, cells bearing both labels are expressing the same surface markers as at Fig. 7 . Labeled EPCs delivered to the heart of infarcted pigs, engraft within the heart, persist for 6 wk and maintain a progenitor phenotype. Each panel of images shows single-channel staining for Dragon Green-conjugated super-paramagnetic iron oxide particles, Cell Tracker Orange CMTMR, Cy5-labeled antibody of interest, DAPI nuclear stain, merged fluorescence images, and merged fluorescence images with overlaid bright-field micrographs. Antibody stains are as follows: anti-human KDR (A), anti-human CD133 (B), anti-porcine CD34 (C), anti-porcine CD45 (D), anti-human CD146 (E), and anti-porcine CD34 (F). the time of transplantation, and macrophages were seen to be separate and distinct from the iron-fluorescence-containing cells, is consistent with persistence of a small number of the original cells still displaying a progenitor phenotype (Figs. 6 and 7) .
We observed significant improvements in LVEF and infarct volume in the cell-treated animals over the 6-wk study period, while untreated animals demonstrated a decline in LVEF. It is important to note that this study was not intended primarily to assess the efficacy of cell therapy in this model and is underpowered to do so. Nonetheless, a number of earlier studies using various cell preparations have shown improvement in systolic cardiac function of a similar magnitude, in both animal and human studies (22) . The mechanism of any benefit seen in this study was not explored. Long-term persistence of transplanted BMCs raises the possibility that these cells may have contributed directly to revascularization or repair of the infarct area, although it is more likely that this was achieved by paracrine means (14, 19, 20, 32) , in view of the fact that the majority of cells were lost in the week following transplantation.
Study Limitations
Within the field of cell therapy, there has been interest in a subset of BMCs, previously termed endothelial progenitor cells (EPCs), and their role in vascular risk and repair (8) . These cells were identified according to surface marker expression, including CD133 and CD34. However, concerns arose with regard to accurate identification of these cells and the infrequency with which they are found in the circulation, and the term "endothelial progenitor cells" has been recently called into question (25a, 27) . In this study, we cultured the mononuclear fraction in a manner which consistently results in "EPCs" in other species (15, 30, 31) and similar to protocols that have been employed in clinical trials (TOP CARE). There is a possibility that we have not administered EPCs per se, but we feel that the culture conditions and phenotypic appearance of the cells make it likely they are committed to an endothelial lineage. For clarity, we feel referring to them as "bone marrow progenitor cells" is a more correct term to reflect this uncertainty.
The actual size of infarction induced was fairly small (at ϳ10% of LV mass). The pig coronary circulation is poorly collateralized, and infarctions involving Ͼ18% of LV mass are invariably fatal.
Conclusion
Following MI, and the intracoronary delivery of magnetically labeled EPCs, it is possible to track the persistence and diffuse distribution of these cells out to 6 wk using MRI. Furthermore, administration of these cells resulted in improvement in LV systolic function and infarct volume.
